Hakan Goker, managing director at M Ventures, and Maina Bhaman, partner at Sofinnova Partners, discussed the current state of the UK biotech sector and its future prospects in an episode of Denatured released on June 25.
The conversation explored several aspects of the UK biotech ecosystem, including changes within the Golden Triangle—a term referring to the biotechnology hubs located between London, Oxford, and Cambridge. The guests addressed ongoing challenges such as scaling companies beyond early-stage development and unlocking pension capital to support industry growth.
Jennifer C. Smith-Parker, director of insights at BioSpace and host of the episode, guided a discussion that also touched on how UK biotech firms can maintain their competitiveness on a global scale. Both Goker and Bhaman provided perspectives from their experience working with venture capital firms that invest in life sciences.
A disclaimer noted that "the views expressed in this discussion by guests are their own and do not represent those of their organizations." No further background or historical context was provided during this episode.
